Recent News

Onglyza Lawsuit Claims AstraZeneca Hid Saxagliptin Heart Failure Risks

Posted on August 13, 2018 by Sandy Liebhard

A plaintiff from Georgia has filed a new Onglyza lawsuit that accuses AstraZeneca of concealing the potential for heart failure and other side effects allegedly associated with saxagliptin, the active ingredient in the Type 2 diabetes medication. Plaintiff Would Not … Continue reading →

Additional Manufacturer Added to Valsartan Heart Drug Recall

Posted on August 13, 2018 by Laurie Villanueva

The U.S. Food & Drug Administration (FDA) has added tablets marketed by another manufacturer to the massive valsartan recall for blood pressure and heart medications that may contain a cancer-causing chemical. Camber Pharmaceuticals Valsartan Recall The recall expansion was announced … Continue reading →

Bard Hernia Mesh Lawsuits Consolidated in Ohio Federal Court

Posted on August 10, 2018 by Laurie Villanueva

A federal judicial panel has agreed to create a multidistrict litigation for all federally-filed hernia mesh lawsuits involving polypropylene devices marketed by C.R. Bard, Inc. and its Davol, Inc. subsidiary. More than 100 Bard Hernia Mesh Lawsuits Pending in Federal … Continue reading →

2017 Was Record Year for Vaccine Injury Claims

Posted on July 30, 2018 by Sandy Liebhard

More than 1,200 claims were filed with the National Vaccine Injury Compensation Program (NVICP) during the last fiscal year, the most in a decade. According to data from the federal Health Resources and Services Administration (HRSA), a total of 1,243 … Continue reading →

Bard IVC Filer Lawsuit Cleared for September Bellwether Trial

Posted on July 30, 2018 by Laurie Villanueva

A lawsuit involving C.R. Bard’s G2X retrievable IVC filter will be heading to trial in September, after a federal judge in Arizona refused a defense bid for summary judgment on claims for negligent design, negligence per se, strict liability, design … Continue reading →

Early Study Results Link Tivicay to Neural Tube Birth Defects

Posted on July 27, 2018 by Laurie Villanueva

Pregnant women who were taking Tivicay at conception may be more likely to have a child with neural tube defects compared to those treated with other, non-dolutegravir-based HIV medications, according to preliminary findings of an ongoing study. How Was the Study … Continue reading →

Talcum Powder Lawsuit: Johnson & Johnson Faces International Fallout from Cancer Litigation

Posted on July 27, 2018 by Sandy Liebhard

Health regulators in India have ordered Johnson & Johnson to disclose all ingredients contained in its talcum powder products, amid allegations that the talc used to manufacturer Baby Powder and other popular brands is carcinogenic. Demand for Talc Ingredients Follows … Continue reading →

Prilosec Wrongful Death Lawsuit Joins Federal Kidney Injury Litigation

Posted on July 26, 2018 by Laurie Villanueva

A wrongful death lawsuit has been filed against the manufacturers of Prilosec, one of the most recent additions to the federal proton pump inhibitor litigation now underway in the U.S. District Court, District of New Jersey. According to a Short … Continue reading →

Study Suggests IVC Filter Offer No Benefit Following DVT Catheter Procedure

Posted on July 26, 2018 by Laurie Villanueva

A recent study is raising doubts about the value of inferior vena cava (IVC) filters following catheter-directed thrombolysis for deep vein thrombosis (DVT). Catheter-Directed Thrombolytic Therapy and DVT Catheter-directed thrombolytic therapy is used to dissolve acute DVT, a serious type … Continue reading →

C.R. Bard Hernia Mesh Lawsuits Continue, With Recent Filings in Ohio and California

Posted on July 25, 2018 by Sandy Liebhard

C.R. Bard, Inc. continues to face a growing number of lawsuits involving allegedly defective polypropylene hernia mesh products. Most recently, two new hernia mesh lawsuits were filed in Ohio and California federal courts on behalf of individuals who claim to … Continue reading →